☆ 4.3 Article

New Directions in Antiplatelet Therapy

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)

Get Full Text
Add to Collection

Journal

CIRCULATION-CARDIOVASCULAR INTERVENTIONS
Volume 5, Issue 3, Pages 433-445

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCINTERVENTIONS.111.966176

Keywords

acute coronary syndrome; antiplatelet therapy; percutaneous transluminal coronary angioplasty; pharmacology; platelets

Categories

Cardiac & Cardiovascular Systems

Funding

  1. Bristol Myers Squibb
  2. Sanofi-Aventis
  3. Eli Lilly Co.
  4. Daiichi Sankyo, Inc.
  5. Medicines Company
  6. Portola
  7. Novartis
  8. Medicure
  9. Accumetrics
  10. Arena Pharmaceutical
  11. Merck
  12. Evolva
  13. Abbott Vascular
  14. GlaxoSmithKline
  15. Otsuka
  16. Schering-Plough
  17. Astra-Zeneca
  18. Eisai

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.